Clinical Trials Browser

Phase 3 × Thalidomide × Lymphoid × Clear all

NCT02085655 2021-03-15

PEG-ASP+Gemox Regimen and Thalidomide for NK/T Lymphoma

Phase 3 Unknown

Lymphoma, Extranodal NK-T-Cell

NCT03016000 2017-07-28

Thalidomide Maintenance Treatment in DLBCL

Phase 3 Unknown

Lymphoma, Large B-Cell, Diffuse